tirzepatide and cancer 💊 Weight-loss drug shows cancer-fighting potential Researchers at the University of Michigan discovered that (Mounjaro, Zepbound), already FDA-approved for diabetes obesity, also shrinks breast tumors in obese mice. When Mouse Study Finds Tirzepatide Slowed

Tutto ci contribuisce a creare condizioni pi favorevoli per la funzione ovarica

A systematic review of over 94,000 adults seeking obesity treatment found that 14% had binge eating disorder on clinical interview and up to 26% reported moderate-to-severe binge eating on self-report measures ( Melville et al., Int J Eating Disorders, 2025 )

Research shows that people taking 96 to 200 mg/day of topiramate lose an average of 5 to 10% of their body weight

Any time you lose weight, you lose both fat and muscle

While these medications may improve enzyme levels in patients with metabolic liver disease, alternative causesincluding viral hepatitis, hemochromatosis, autoimmune conditions, or medication effectsmust be excluded

Makowski was featured in an article for Nature Reviews Cancer called Are GLP-1 receptor antagonists a magic bullet for cancer? Very little is known, but what were discovering is that it changes lots of different factors that circulate in our blood and that we think are going to affect your immune system, said Makowski